𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children

✍ Scribed by M. Landin-Olsson; J. P. Palmer; Å. Lernmarks; L. Blom; G. Sundkvist; L. Nyström; G. Dahlquist

Publisher
Springer
Year
1992
Tongue
English
Weight
833 KB
Volume
35
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Islet cell and insulin autoantibodies in
Islet cell and insulin autoantibodies in subjects at high risk for development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon family study
✍ Ch. Thivolet; B. Beaufrére; H. Bétuel; L. Gebuhrer; P. Chatelain; A. Durand; J. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 748 KB

Genetic determination as well as prospective analysis of islet cell autoantibodies and autoantibodies to insulin were conducted in a population of 479 first degree relatives of 174 Type 1 (insulin-dependent) diabetic patients. Analysis of HLA haplotypes within families illustrated the high frequency

Islet cell and insulin autoantibodies in
Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of Type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study
✍ C. Betterle; F. Presotto; B. Pedini; L. Moro; R. S. Slack; F. Zanette; R. Zanche 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 530 KB

To evaluate the behaviour and predictive value of islet cell and insulin autoantibodies in patients with organ-specific autoimmune diseases, we followed 21 non-diabetic subjects for a mean period of 84 +/- 27 months. Ten patients were persistently seropositive for complement-fixing islet cell antibo

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune

Mortality in Israeli Jewish patients wit
Mortality in Israeli Jewish patients with Type 1 (insulin-dependent) diabetes mellitus diagnosed prior to 18 years of age: a population based study
✍ M. Modan; M. Karp; B. Bauman; O. Gordon; Y. L. Danon; Z. Laron 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 669 KB

A total of 614 Jewish patients under the age of 18 with Type 1 (insulin-dependent) diabetes mellitus, diagnosed in Israel during the period 1 January 1965 to 31 December 1979, were identified by exhaustive screening of all possible sources. Mortality experience of this cohort was updated to 31 March

Ketone bodies as markers for Type 1 (ins
Ketone bodies as markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control
✍ Y. Harano; K. Kosugi; T. Hyosu; M. Suzuki; H. Hidaka; A. Kashiwagi; S. Uno; Y. S 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 595 KB

Serum levels of acetoacetate, 3-hydroxybutyrate and the 3-hydroxybutyrate/acetoacetate ratio were determined in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients by a new sensitive method. Efforts were made to differentiate Type 1 and Type 2 diabetes by serum levels of